Discuss on the Risk Control of Traditional Chinese Medicine

Chinese Journal of Pharmacovigilance ›› 2010, Vol. 7 ›› Issue (10): 607-610.

Previous Articles Next Articles

Discuss on the Risk Control of Traditional Chinese Medicine

WU Cheng-yun¹ ,HUANG Wen-zhi¹, ZHENG Qing-ming¹ ,ZHANG Li², ZHOU Ya-li¹ ,ZHANG Cheng-xu^2*

1.Sichuan Food and Drug Safety Monitoring and Evaluation Certification Center, Sichuan Chengdu 610017, China;
2.Center for Drug Reevaluation, SFDA, Beijing 100045, China

Received:2009-12-25 Revised:2016-03-12 Online:2010-10-08 Published:2016-03-09

Abstract

Abstract: This essay based on analyzing the pertinent literature, unscrambling the correlative laws and regulations of drug administration in force, and combining the situation of Traditional Chinese Medicine(TCM), The influential factors of TCM safety were discussed; as for the organizations relative to TCM, the responsibility and obligation were determined to controlling the risks from TCM, how and take what measures to decrease the risks were stated as well.

Key words: Traditional Chinese Medicine(TCM), risk control, adverse drug reaction(ADR)

CLC Number:

R954

WU Cheng-yun ,HUANG Wen-zhi, ZHENG Qing-ming ,ZHANG Li, ZHOU Ya-li ,ZHANG Cheng-xu . Discuss on the Risk Control of Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2010, 7(10): 607-610.

[1]	HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia. 535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
[2]	. Annual report of national adverse drug reaction monitoring (2022) [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 712-719.
[3]	ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei. Analysis of neuropsychiatric adverse reactions caused by zolpidem [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
[4]	ZHAO Yan, ZHAO Yifei^△, ZHENG Lijia, DONG Fang. Medical Device Vigilance Systems in European Union [J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 566-569.
[5]	SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng. Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions [J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
[6]	DENG Xia, LIU Bo, WANG Yuanzheng, YIN Xiao, SU Yao, ZHANG Yan, LI Yingli, GAO Chenyan, YANG Huan, WANG Tao. Antibody-Dependent Enhancement of Vaccines and Development of Coronavirus Vaccines [J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 201-205.
[7]	CHENG Jinlian, OUYANG Huitian, JIN Hongtao, ZHU Xueqi, XIAO Shuang, LEI Xiang, GAO Chunsheng, LIU Qingquan. Thoughts and Suggestions on Safety Evaluation of Combined use of Traditional Chinese Medicine in Clinical Research [J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 4-10.
[8]	PENG Shirong, CHEN Haiyan, WANG Qian, DING Qian, WANG Xiaoling. Risk Management of Pediatric Drug Clinical Trials [J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 564-566.
[9]	WENG Lihong, GAO Huan, HU Xue, ZHANG Wenrui. Infusion Requirements on Labels of 39 Chinese Traditional Medicine Injections [J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 437-440.
[10]	LYU Tianyi, KUANG Li, CHEN Mingying. Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram [J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
[11]	XU Shungui. 105 Cases of Adverse Drug Reactions Indcued by Ibuprofen in Our Hosptial [J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 164-167.
[12]	LIU Chen, CHU Yanqi, YAN Suying, JIN Chao, LIU Tong, XING Liqiu, ZHANG Xiao. Analysis of 93 Reports of Adverse Drug Reactions Induced by Edaravone Injection [J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 174-178.
[13]	ZHAO Cui-hong, TAO Yi-xiu, WANG Sheng-hai, ZHAO Qiang, MENG Qing-yong, ZHANG Han-xiang, QING Ming-ying, MA Wen-xia, MI Man. Study on Related Factors of Postoperative Nausea and Vomiting and Clinical Intervention in Patients with Intraspinal Anesthesia [J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 201-204.
[14]	ZHAO Rui, CUI Xiangli, LIU Lihong. Pharmaceutical Care of a Patient with Hydroxychloroquine Induced Long QT Syndrome [J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 690-692.
[15]	WANG Lin, LI Shuang, LI Hua-bin, JU Yong-jing. Analysis of Adverse Drug Reactions about 141 Cases of Dextran 40 and Amino Acids Injection [J]. Chinese Journal of Pharmacovigilance, 2018, 15(1): 45-48.

Discuss on the Risk Control of Traditional Chinese Medicine

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics